Long-term outcomes of kidney transplantation in a transfusion-dependent alpha-thalassemia patient

Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. Lancet. 2018;391(10116):155–67.

PubMed  Google Scholar 

Jalil T, Yousafzai YM, Rashid I, Ahmed S, Ali A, Fatima S, et al. Mutational analysis of beta thalassaemia by multiplex ARMS-PCR in Khyber Pakhtunkhwa, Pakistan. J Ayub Med Coll Abbottabad. 2019;31(1):98–103.

PubMed  Google Scholar 

Goh LPW, Chong ETJ, Lee P-C. Prevalence of alpha (α)-thalassemia in Southeast Asia (2010–2020): a meta-analysis involving 83,674 subjects. Int J Environ Res Public Health. 2020;17(20):7354.

PubMed  PubMed Central  Google Scholar 

Demosthenous C, Vlachaki E, Apostolou C, Eleftheriou P, Kotsiafti A, Vetsiou E, et al. Beta-thalassemia: renal complications and mechanisms: a narrative review. Hematology. 2019;24(1):426–38.

CAS  PubMed  Google Scholar 

KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4s):S117-314. https://doi.org/10.1016/j.kint.2023.10.018.

Joher N, Matignon M, Grimbert P. HLA desensitization in solid organ transplantation: anti-CD38 to across the immunological barriers. Front Immunol. 2021;12: 688301.

CAS  PubMed  PubMed Central  Google Scholar 

Emam M, Moneem MA, Gheith O, Mahmoud T, Nagib AM, Abdultawab K, et al. Successful kidney transplantation of a patient with thalassemia major: case report and review of literature. J Egypt Soc Nephrol Transplant. 2021;21(3):144–7.

Google Scholar 

Kalamara T-VN, Zarkada EG, Kasimatis ED, Kofinas AG, Klonizakis PI, Vlachaki EC. Kidney transplantation in an adult with transfusion-dependent beta thalassemia: a challenging case report and literature review. Arch Clin Cases. 2023;10(2):97.

PubMed  PubMed Central  Google Scholar 

Sleiman J, Tarhini A, Taher AT. Renal complications in thalassemia. Thalassemia Rep. 2018;8(1):74–81.

Google Scholar 

Quinn CT, Johnson VL, Kim HY, Trachtenberg F, Vogiatzi MG, Kwiatkowski JL, et al. Renal dysfunction in patients with thalassaemia. Br J Haematol. 2011;153(1):111–7. https://doi.org/10.1111/j.1365-2141.2010.08477.x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haddad A, Tyan P, Radwan A, Mallat N, Taher A. Β-thalassemia intermedia: a bird’s-eye view. Turk J Hematol. 2014;31(1):5.

Google Scholar 

Adramerina A, Economou M. Challenges of iron chelation in thalassemic children. Thalass Rep. 2024;14(1):1–9.

CAS  Google Scholar 

Wouk N. End-stage renal disease: medical management. Am Fam Physician. 2021;104(5):493–9.

PubMed  Google Scholar 

Abbas F, El Kossi M, Shaheen IS, Sharma A, Halawa A. Drug-induced myelosuppression in kidney transplant patients. Exp Clin Transplant. 2021;19(10):999–1013.

PubMed  Google Scholar 

Scornik J, Meier-Kriesche H-U. Blood transfusions in organ transplant patients: mechanisms of sensitization and implications for prevention. Am J Transplant. 2011;11(9):1785–91.

CAS  PubMed  Google Scholar 

Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, et al. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia. Blood. 2006;107(9):3455–62.

CAS  PubMed  Google Scholar 

Weinstock C, Schnaidt M. Human leucocyte antigen sensitisation and its impact on transfusion practice. Transfus Med Hemother. 2019;46(5):356–69.

PubMed  PubMed Central  Google Scholar 

Sobiak J, Kamińska J, Głyda M, Duda G, Chrzanowska M. Effect of mycophenolate mofetil on hematological side effects incidence in renal transplant recipients. Clin Transplant. 2013;27(4):E407–14.

CAS  PubMed  Google Scholar 

Datrino LN, Boccuzzi ML, Silva RM, Castilho PHBT, Riva WJ, Rocha JS, et al. Safety and efficacy of mycophenolate mofetil associated with tacrolimus for kidney-pancreas and kidney transplantation: a systematic review and meta-analysis of randomized studies. Transplant Proc. 2024;56(5):1066–76. https://doi.org/10.1016/j.transproceed.2024.05.014.

Article  CAS  PubMed  Google Scholar 

Dave V, Polkinghorne KR, Leong KG, Kanellis J, Mulley WR. Initial mycophenolate dose in tacrolimus treated renal transplant recipients, a cohort study comparing leukopaenia, rejection and long-term graft function. Sci Rep. 2020;10(1):19379. https://doi.org/10.1038/s41598-020-76379-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nampoory MR, Johny KV, Al-Hilali N, Seshadri MS, Kanagasabhapathy AS. Erythropoietin deficiency and relative resistance cause anaemia in post-renal transplant recipients with normal renal function. Nephrol Dial Transplant. 1996;11(1):177–81.

CAS  PubMed  Google Scholar 

Comments (0)

No login
gif